Searching the Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Ovarian reserve describes a woman's reproductive potential and there are a variety of tests for this. This reflects the lack of a gold standard and the lack of a single test that provides sufficient accuracy. Ovarian biopsy has been proposed as a potential tool for assessing the ovarian reserve and therefore the ability or inability for a woman to bear a child with or without treatment. The literature assessing the diagnostic accuracy of ovarian biopsy as a test of ovarian reserve for predicting fertility outcomes (live birth rate, ongoing pregnancy, clinical pregnancy, biochemical pregnancy, embryos available, oocytes retrieved or cancelled cycles) was systematically reviewed. There were no studies identified that assessed the diagnostic accuracy of ovarian biopsy for predicting fertility outcomes but a number of studies provided evidence that ovarian follicles are distributed unevenly and randomly throughout the ovarian cortex. This leads to sampling error when ovarian biopsy is used to sample the ovarian reserve. It is concluded that ovarian biopsy should not be used as a test of ovarian reserve. Every woman is born with a limited number of eggs, and as women age, their ability to have children eventually decreases to zero due to the loss of these eggs. Ovarian reserve is a term that describes the remaining pool of eggs. Testing for ovarian reserve enables one to predict the ability or inability of a woman to have a child and how long a woman may be able to defer having a child. This is of importance as social trends in developed countries are leading to increasing numbers of women who have children at later stages of their lives. One test of ovarian reserve is an ovarian biopsy, where a woman undergoes an operation to have a small piece of her ovary removed. The number of eggs in this removed piece is counted, and from this, the number of eggs in the whole ovary can be estimated and calculated. We reviewed the literature for all studies that examined the accuracy of ovarian biopsy to predict fertility outcomes but found no studies that answered this question. A number of studies have found that eggs are distributed unevenly and randomly in an ovary. As such, the number of eggs in an ovarian biopsy sample does not represent the actual number of eggs remaining in the ovary. Because of this and the risks inherent in the operation to perform this test, we believe that ovarian biopsy should not be used as a test of ovarian reserve.
Pubmed ID: 22414372
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
A bibliographic database that provides a highly concentrated source of reports of randomized controlled trials. Records contain the list of authors, the title of the article, the source, volume, issue, page numbers, and, in many cases, a summary of the article (abstract). They do not contain the full text of the article. Cochrane Groups maintain and update Specialized Registers, which are collections of controlled trials relevant to the groups. CENTRAL is comprised of these Specialized Registers, relevant records retrieved from MEDLINE and EMBASE, and records retrieved through handsearching (planned manual searching of a journal or conference proceedings to identify all reports of randomized controlled trials and controlled clinical trials). The Cochrane Collaboration contracts a technology company, Metaxis, to merge the records from the sources outlined above and provide a data feed to the publisher. New and changed data are delivered to the publisher on a monthly basis.
View all literature mentions